Back to search
FDAFDA · Food and drugs·Recall number Z-0892-2022

First SIGN SARS-CoV-2 Antigen Test

Published April 13, 2022 · Recall initiated: March 4, 2022

Summary

FDA records medical device Class II recall Z-0892-2022, published April 13, 2022 and initiated March 4, 2022. Recalling firm: WHPM Inc.; Status: Terminated; Reported quantity: 535,755 tests; Lot: Model Number: FSSA-CK20 UDI Codes: None Lot Numbers: F0301214078; F1227210039; F0809210004; F0906210010; P0211214070; F0914210014; F1013210020; F1214210034; F0121220041. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Frm became aware that a customer complaint was reported to US FDA that SARS-CoV-2 Antigen Tests were sold domestically by a pharmacy in California. These Antigen Tests have not received FDA Emergency Use Authorization, nor have these tests been cleared or approved by FDA for commercial distribution in the U.S.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
WHPM Inc.
Distributor
U.S.: CA, FL, LA, MA and TX O.U.S.: N/A
Lot
Model Number: FSSA-CK20 UDI Codes: None Lot Numbers: F0301214078; F1227210039; F0809210004; F0906210010; P0211214070; F0914210014; F1013210020; F1214210034; F0121220041;
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was First SIGN SARS-CoV-2 Antigen Test recalled?

Yes. FDA published recall Z-0892-2022 on April 13, 2022. Reported hazard: Frm became aware that a customer complaint was reported to US FDA that SARS-CoV-2 Antigen Tests were sold domestically by a pharmacy in California. These Antigen Tests have not received FDA Emergency Use Authorization, nor have these tests been cleared or approved by FDA for commercial distribution in the U.S.

What should I do if I have this product?

Voluntary: Firm initiated · Letter